Prolung Inc 's

• FRES's Stock Performance relative to its Competitors

Astrazeneca Plc Share Performance -9.89% This Year

Astrazeneca Plc Profile AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks. More about Astrazeneca Plc's Market Share

Surgalign Holdings Inc Share Performance -77.45% 30 Days

Surgalign Holdings Inc Profile Surgalign Holdings Inc operates as a medical technology company that provides innovative products for spinal surgeries. Their business model involves developing and manufacturing medical devices, implants, and instruments used in various spinal procedures. Surgalign focuses on delivering solutions that improve surgical outcomes and patient experiences in collaboration with healthcare professionals worldwide. More about Surgalign Holdings Inc 's Market Share

Si bone inc Share Performance +17.57% This Quarter

Si bone inc Profile SiBone Inc's business model revolves around the development and commercialization of innovative medical devices for the treatment of musculoskeletal disorders, particularly focused on the utilization of their patented iFuse Implant System. More about Si bone inc 's Market Share

Resmed Inc Share Performance -4.37% 30 Days

Resmed Inc Profile ResMed Inc is a medical equipment company focused on creating and manufacturing products for the treatment of sleep apnea and other respiratory conditions. Their business model includes a combination of direct sales and partnerships with healthcare providers, ensuring wide distribution of their devices to patients worldwide. By leveraging advanced technology and data-driven solutions, ResMed aims to enhance patient care and improve health outcomes for individuals with sleep-related breathing issues. More about Resmed Inc 's Market Share

Ovid Therapeutics Inc Share Performance +46.02% This Year

Ovid Therapeutics Inc Profile Ovid Therapeutics Inc's business model is focused on developing and commercializing innovative medicines for the treatment of rare neurological disorders. More about Ovid Therapeutics Inc 's Market Share

Sources: Prolung Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 4:47 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Prolung Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.